Wegovy for Weight Loss
Prescribed online through TOM Weight Loss
Wegovy is the first GLP-1 medication FDA-approved specifically for chronic weight management. At TOM Weight Loss, our licensed providers prescribe Wegovy online to patients across Texas and Utah. No waiting rooms, no referrals. Just clinical care that meets you where you are.
What Is Wegovy?
Wegovy is a once-weekly injectable GLP-1 medication containing semaglutide, FDA-approved specifically for chronic weight management in adults with obesity or overweight with at least one related health condition.
Understanding Wegovy for Weight Loss
What sets Wegovy apart from other semaglutide medications is its FDA indication. It was purpose-built for weight loss, approved at a higher dose than Ozempic , and backed by some of the strongest clinical trial data in the history of weight management medicine.
Its active ingredient, semaglutide , works by mimicking a naturally occurring gut hormone to reduce appetite, slow digestion, and signal fullness to your brain. It's not a short-term fix; it's a clinically supported tool for sustained weight loss when diet and exercise alone haven't been enough.
Whether you're prescribed Wegovy or compounded semaglutide , the core mechanism is identical. At TOM Weight Loss, our providers will help determine which semaglutide-based option fits your goals, budget, and medical history.
Why Patients Choose Wegovy
- FDA-approved specifically for chronic weight management
- Clinically proven 15-17% average body weight loss
- Higher max dose than Ozempic, stronger average results
- Once-weekly injection, minimal disruption to daily life
- Backed by the STEP clinical trial program
- Available as compounded semaglutide for cost savings
- Fully managed through physician-led telehealth care
- Prescribed and monitored by licensed Texas providers
How Does Wegovy Work for Weight Loss?
Wegovy is a GLP-1 receptor agonist. GLP-1 is a hormone your gut releases after eating; it tells your brain you're full, slows stomach emptying, and stabilizes blood sugar. Wegovy mimics that signal at a sustained level throughout the week.
Activates GLP-1 Receptors
Wegovy binds to GLP-1 receptors in your gut, pancreas, and brain, the same receptors triggered by your body's natural fullness hormones after a meal. This is the foundation of how the medication works.
Reduces Appetite
By activating GLP-1 receptors in the brain, Wegovy suppresses appetite signals throughout the week. Most patients report eating significantly less without feeling deprived; that's pharmacology, not willpower.
Slows Digestion
Wegovy slows the rate at which your stomach empties, meaning food stays in your system longer. This extends feelings of fullness and naturally reduces how much you eat at each meal.
Stabilizes Blood Sugar
Semaglutide helps regulate blood sugar by supporting insulin response after meals. More stable blood sugar means fewer energy crashes, reduced cravings, and less likelihood of reaching for food out of habit.
Reduces Cravings
Patients commonly report a quieting of food cravings on Wegovy. The combination of appetite suppression, blood sugar stability, and hormonal signaling makes it easier to stay consistent over time.
Supports Sustained Weight Loss
The STEP clinical trials showed patients on Wegovy losing an average of 15-17% of body weight over 68 weeks. In some trials patients lost over 20%. Results compound over the first 6-12 months of consistent use.
Wegovy Dosing - What to Expect Week by Week
Wegovy follows a five-step titration schedule reaching a maximum of 2.4mg weekly. Starting low and increasing gradually minimises side effects while maximising long-term results. Your TOM Weight Loss provider will manage every dose adjustment.
| Phase | Dose | What typically happens | Provider action |
|---|---|---|---|
| Weeks 1-4 |
0.25mg | Body adjusts to the medication. Mild appetite changes for most patients. Side effects, if any, are typically minimal at this stage. | Baseline check-in, side effect review |
| Weeks 5-8 |
0.5mg | Appetite suppression becomes more noticeable. Early weight loss begins for most patients. | Dose increase confirmed if tolerated |
| Weeks 9-12 |
1mg | Continued weight loss. Side effects typically settling as the body adjusts to higher dosing. | Progress check, tolerability assessment |
| Weeks 13-16 |
1.7mg | Stronger appetite reduction. Weight loss accelerating. Most patients are seeing meaningful results by this point. | Progress assessment, dose optimisation |
| Week 17+ | 2.4mg (maintenance) | Full therapeutic dose reached. Most significant weight loss results occur at this stage. Ongoing management continues. | Long-term plan review |
Wegovy Side Effects - What You Need to Know
Understanding Wegovy side effects is an important part of starting treatment with confidence. Most side effects are gastrointestinal and most pronounced when first starting the medication or increasing the dose.
Nausea
The most frequently reported side effect across Wegovy's STEP clinical trials. Most pronounced during the earlier doses and at each escalation point. The five-step titration is designed specifically to give your body time to adjust before each increase.
Digestive Symptoms
Diarrhea, constipation, vomiting, and stomach discomfort are common across the titration schedule. Symptoms tend to be most intense at the 0.5mg and 1mg stages before easing as the body adapts to higher doses.
Reduced Appetite
For most patients this is the intended effect of treatment rather than a concern. Appetite reduction typically becomes more pronounced as the dose increases, which is part of how Wegovy produces sustained weight loss.
Headache and Fatigue
Some patients report headaches and low energy in the early stages of treatment or following a dose increase to 1.7mg or 2.4mg. Both typically resolve within a few weeks as the body stabilises at the new dose level.
Less Common but Serious
Rare but documented in Wegovy trials: pancreatitis, gallbladder disease, increased resting heart rate, and suicidal ideation. Patients with a mental health history should discuss this with their provider before starting treatment.
Managing Side Effects
Wegovy's five-step titration gives more checkpoints to catch and manage side effects before they become a reason to stop treatment. TOM Weight Loss providers adjust pace, provide dietary guidance, and are available throughout your full titration journey.
Wegovy vs. Other GLP-1 Medications
Not all GLP-1 medications are the same. Here's how Wegovy stacks up against Ozempic, Mounjaro, and Zepbound, all available through TOM Weight Loss.
| Medication | Active Ingredient | Mechanism | FDA Approval | Max Weekly Dose | Avg. Weight Loss |
|---|---|---|---|---|---|
| Wegovy | Semaglutide | GLP-1 agonist | Chronic weight management | 2.4mg | 15-17% |
| Ozempic | Semaglutide | GLP-1 agonist | Type 2 diabetes | 2mg | 10-15% |
| Mounjaro | Tirzepatide | GLP-1 + GIP dual agonist | Type 2 diabetes | 15mg | 20-22% |
| Zepbound | Tirzepatide | GLP-1 + GIP dual agonist | Chronic weight management | 15mg | 20-22% |
All four medications are available through TOM Weight Loss. Your provider will help determine the right option based on your health history, goals, and budget. Not sure where to start? Check our GLP-1 eligibility guide →
Who Qualifies for Wegovy?
Wegovy can be a strong fit for patients who want physician-guided medical weight loss with a medication that has an FDA approval built specifically around obesity treatment. Eligibility is determined following a full clinical consultation.
BMI and eligibility requirements
Wegovy is FDA-approved for adults who meet one of the following:
- BMI of 27+ with at least one weight-related condition (high blood pressure, high cholesterol, type 2 diabetes, or sleep apnea)
- BMI of 30+ regardless of other conditions
- Have tried diet and exercise without sustainable results
- Want physician-led, ongoing weight loss support
Not sure if you qualify? Check our full GLP-1 eligibility guide →
Medical conditions that may affect eligibility
Wegovy is not suitable for patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2), or during pregnancy. Your provider will review your full history before prescribing.
Your TOM provider will review your full medical history, current medications, and any contraindications before prescribing. A real clinical consultation, not just a questionnaire, is what protects both your safety and your results.
If Wegovy isn't the right fit, your provider will discuss alternative options including Ozempic , Mounjaro , Zepbound , or oral medications.
How to Get Wegovy Online Through TOM Weight Loss
TOM Weight Loss is a physician-led online weight loss clinic. Getting started with Wegovy is straightforward, fully virtual, and takes less than a week from consultation to first dose.
Free Consultation
Meet virtually with a board-certified physician who reviews your goals, health history, and whether Wegovy is the right fit for you.
Personalised Plan
Your physician selects the right semaglutide option, starting dose, and five-step titration schedule based on your body and goals.
Prescription and Delivery
Your prescription is fulfilled through a licensed pharmacy and shipped directly to your door, typically within 1-3 days of approval.
Ongoing Support
Regular follow-ups, 24/7 provider access, and dose adjustments keep your treatment on track from first injection to goal weight.
Wegovy Online From a Texas-Based Weight Loss Clinic
TOM Weight Loss is a Texas-based online weight loss clinic providing physician-guided Wegovy treatment to patients across Texas and Utah. Our licensed providers build personalised plans around your goals, with real clinical oversight from consultation through to long-term results. No in-office visit required.
Wegovy FAQs
Common questions about Wegovy for weight loss, side effects, dosing, and how it compares to other GLP-1 medications. Can't find your answer? Call us at 713-568-9101.
Wegovy is FDA-approved for chronic weight management in adults who are obese or overweight with at least one related health condition. It's a long-term treatment, not a short-term intervention, designed for patients who need more than lifestyle changes alone.
Wegovy mimics GLP-1, a gut hormone that signals fullness, slows digestion, and stabilizes blood sugar. Injected once weekly, it keeps those signals elevated throughout the week, reducing hunger and overall caloric intake without relying on willpower alone.
They contain the same active ingredient, semaglutide, but are not the same medication. Wegovy is FDA-approved for weight management and dosed up to 2.4mg weekly. Ozempic is approved for type 2 diabetes and maxes at 2mg. Wegovy's higher dose is a key reason it typically produces greater average weight loss.
For the right patient, yes. Wegovy has been through one of the most extensive clinical trial programs of any weight loss medication, the STEP trials, and has a well-established safety profile. Safety comes down to appropriate patient selection, careful titration, and ongoing clinical monitoring. That's exactly what TOM Weight Loss provides.
The most common side effects are nausea, vomiting, diarrhea, constipation, headache, and fatigue, most pronounced when starting the medication or increasing the dose. They typically improve within a few weeks as your body adjusts to each dose level. Starting low and titrating slowly significantly reduces their severity.
Clinical trials showed an average of 15-17% body weight loss over 68 weeks. Individual results vary based on dose, adherence, and lifestyle factors, but Wegovy has the strongest weight loss data of any semaglutide medication on the market. Some patients in trials lost over 20%.
Through TOM Weight Loss, you can get Wegovy online via a telehealth consultation with a licensed provider. Complete an intake form, meet with your provider virtually, receive your prescription, and have medication delivered to your door. No in-person visit required.
Yes. If you're not seeing the results you hoped for or want to explore tirzepatide's dual-mechanism approach, your TOM Weight Loss provider can walk you through a transition, including appropriate dose starting points and washout considerations.
Coverage varies by plan. Some insurers cover Wegovy for obesity; others don't. Our team can help you navigate your options and, where insurance falls short, compounded semaglutide is available as a lower-cost alternative starting at $199/month.
Get Started With Wegovy Through TOM Weight Loss
TOM Weight Loss is a Texas-based online weight loss clinic providing physician-guided Wegovy treatment to patients across Texas and Utah. Our licensed providers build personalised plans around your goals, with real clinical oversight from consultation through to long-term results. Ready to find out if Wegovy is right for you?
Prescription required. Not all patients qualify. Physician evaluation required prior to treatment. This page is for informational purposes and does not constitute medical advice. TOM Weight Loss provides telehealth weight management services across Texas and Utah. Results vary.
